Figure 2. Hospital Discharge in a Study of the Effect of a High Dose of Vitamin D3 on Patients With Moderate to Severe Coronavirus Disease 2019.
Vertical bars represent single censored events. A, The median (interquartile range) observation time was not significantly different between the vitamin D3 group (7.0 [4.0-10.0] d) and the placebo group (7.0 [5.0-13.0] d). B, Among the patients with 25-hydroxyvitamin D deficiency, there was no significant difference observed in the median (interquartile range) observation time between the vitamin D3 group (8.0 [4.0-11.5] d) and the placebo group (7.0 [6.0-13.3] d).